bf/NASDAQ:IMMX_icon.jpeg

    COM:IMMIXBIO

    Immix Biopharma, Inc.

    • Stock

    1.68

    −1.18%

    0.03

    USD last updated 03/04 02:03:24

    Last Close

    1.65

    02/04 20:00

    Market Cap

    46.57M

    Beta: -

    Volume Today

    109.65K

    Avg: -

    Description

    Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstre...Show More

    peer of

    investor of